Adult HBV Vaccination: Identifying Individuals at Risk for Reduced Seroprotection

In this episode, learn about the importance of identifying adults at risk for reduced hepatitis B virus (HBV) seroprotection and applying current HBV vaccine recommendations in special populations. Listen as Robert G. Gish, MD, discusses key information on the identification and evaluation of patients who have chronic health conditions and therefore may be at risk for nonresponse to available vaccines.

Presenter: 

Robert G. Gish, MD
Professor of Medicine
Loma Linda University
Loma Linda, California
Adjunct Professor of Medicine
Nevada School of Medicine
Las Vega, Nevada
Clinical Professor
University of Nevada Reno 
School of Medicine
Reno, Nevada
Clinical Professor
University of California Skaggs School of 
Pharmacy and Pharmaceutical Sciences
San Diego, California
Medical Director
Hepatitis B Foundation
Washington, DC

Review the downloadable slidesets at:
https://bit.ly/3KPiJZz

Link to full program:
https://bit.ly/3OZ50Ta

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.